Mast Therapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
Mast Therapeutics Inc. Announces 4Q And Full Year 2016 Financial & Operating Results
Article By: Smarter Analyst
Monday, March 6, 2017 5:54 PM EDT
Mast Therapeutics Inc. reported net loss for the fourth quarter of 2016 was $6.0 million, or $0.02 per share (basic and diluted), compared to a net loss of $10.2 million, or $0.06 per share (basic and diluted), for the same period in 2015.
In this article: MSTX
Read
2 More Triple Digit Winners In Biotech
Article By: Bret Jensen
Monday, February 16, 2015 5:43 AM EDT
The small cap biotech and biopharma complex has been very kind to everyone. Here are two more recommendations that have the signature Bret Jensen “X” factors that make up a great small cap biotech investment.
In this article: THLD, MSTX, AVNR, CRIS, ZIOP
Read
Laidlaw's Yale Jen: Biotech 101 For Buyers And Sellers
Article By: The Life Sciences Report
Friday, August 29, 2014 5:36 AM EDT
Former biotech consultant Yale Jen picked up a few tricks advising companies on their pipelines before he came to Wall Street as a sellside analyst.
In this article: GSK, PFE, ISIS, RPRX, BIIB, MSTX, ADMA, GLYC
Read

Latest Tweets for $MSTX

No tweets yet!

PARTNER HEADLINES